Navigation Links
First Rewards Paid to New Jersey Doctors Through Participation in Bridges to Excellence
Date:3/12/2009

Incentives paid by employers and health plans to physicians meeting quality standards for diabetes care

TRENTON, N.J., March 12 /PRNewswire-USNewswire/ -- Through Bridges to Excellence (BTE), the nation's most extensive effort to recognize and reward high-performing physicians, improve patient health and reduce costs of care, the first rewards are being paid in New Jersey to BTE-recognized doctors. The program was first launched in the Garden State in 2008 by a core group of employers, health plans and physicians working together to address specific goals and standards for quality care for diabetes. Almost 50 physicians will receive the initial incentives.

"The Bridges to Excellence program makes quality a key component in the value equation of health care reform," said Cliff Feldman, executive director, Health and Wellness Benefits for Verizon. "Rewarding doctors who provide higher-quality, evidence-based care, helps drive better results and ultimately lowers health care costs."

Employers instrumental in bringing Bridges to Excellence to New Jersey include Verizon (a founding member of BTE), AstraZeneca, AtlantiCare, Novo Nordisk, Public Service Enterprise Group (PSEG) and Trump Entertainment Resorts. Aetna has shown its commitment to the success of the program by working with employers to include more New Jersey members in the program, including fully insured members, which has resulted in more opportunity for incentives for participating physicians. Other participating health plans are CIGNA, Horizon Blue Cross Blue Shield of New Jersey and UnitedHealthcare, with Aetna, CIGNA and UnitedHealthcare paying initial rewards to physicians.

"Improving the quality and cost of health care requires collaboration and commitment from all stakeholders," said Michael Hudson, president, Northeast Region, Health Care Management for Aetna. "Aetna is proud to be a part of BTE and to work with physicians and
'/>"/>

SOURCE Bridges to Excellence
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mylans Matrix Receives Tentative FDA Approval Under PEPFAR for First Generic, Heat-Stable Version of HIV Protease Inhibitor
2. BridgePoint Medical Completes First U.S. Clinical Case Using CrossBoss and Stingray Devices in CTO Angioplasty Procedure
3. Yankees Will Become First MLB Team to Integrate Highly Advanced Antimicrobial System
4. Cepheid Receives Health Canada License for First On-demand Diagnostic Test for Life-threatening MRSA and S. aureus Infections From Patient Positive Blood Culture Bottles
5. The Nation's First Federally Certified Patient Safety Organization Chooses Quantros Patient Safety Organization Manager
6. Air Methods Announces Year 2008 Financial Results and Provides First Quarter 2009 Update
7. Devicor Medical Products Actively Seeking First Acquisition
8. D.C. Mayor Fenty, Italian Ambassador Help Announce First-Ever Susan G. Komen Global Race for the Cure(R)
9. Security Health Plan Becomes First ICSI Sponsor Outside of Minnesota
10. Less Invasive Interventional Treatment Can Be Recommended as First-Line Treatment for Silent Killer, Abdominal Aortic Aneurysm
11. Cell Biosciences Announces First UK System Sale
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... ... July 30, 2015 , ... ... entitled " Lovetraction Lines ." It's for women interested in improving their love ... desire. The course, which officially launched to the public early this morning, has ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American Telemedicine Association ... and Tradeshow focused exclusively on telemedicine, telehealth and mHealth. The meeting, expected to ... will take place May 14-17, 2016 in Minneapolis, MN. , ATA’s annual meeting ...
(Date:7/30/2015)... ... July 30, 2015 , ... 24/7 Care At Home, a high-quality provider of ... announced that the Centers for Medicare and Medicaid (CMS) have awarded its agency the ... 24/7 Care At Home’s agency is one of three top Orange County agencies to ...
(Date:7/30/2015)... ... , ... Ross A. Clevens, MD, FACS has been reappointed by ... Surgery. This is Dr. Clevens’ second appointment by the prestigious school. Over ... strong presence and a valuable mentoring program for medical students. , ...
(Date:7/30/2015)... California (PRWEB) , ... July 30, 2015 , ... Western ... success of the 2015 Special Olympics World Games, the largest sports and humanitarian event ... the 1984 Olympic Games. , The World Games, held July 25 through August 2, ...
Breaking Medicine News(10 mins):Health News:Lovetraction Lines - Review Examining Simone Myers' New Online Course Released 2Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 2Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 3Health News:24/7 Care At Home Earns a 5-Star Rating from the Centers for Medicare and Medicaid (CMS) 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 2Health News:Leading Melbourne Facial Plastic Surgeon Reappointed by UCF 3Health News:WesternU Makes Big Impact at Special Olympics 2Health News:WesternU Makes Big Impact at Special Olympics 3
... oral cancer, which a dentist could perform by simply using ... set to be developed by researchers at the University of ... The international research team, involving scientists in Sheffield, has been ... to develop the test, which could provide an accurate diagnosis ...
... available in French . Inhibiting prostate cancer ... governs tumour growth A kinase is a type of ... proteins required for cell growth and maintenance, and researchers have ... developing prostate cancer. "It,s known as Mnk, and although it ...
... College of Nursing has been awarded a $753,817 grant ... Health Resources and Services Administration (HRSA), to prepare advanced ... high quality healthcare in rural and medically underserved urban ... to i-LEAD, Innovation in Leadership and Administration in Nursing ...
... Comprehensive Cancer Center and the departments of Chemistry ... uncovered a role for an essential cell protein ... "power plant" of the cell. The import ... for the replication, transcription and translation of the ...
... is twofold, as the patients not only suffer from ... called phantom pain. Unlike bodily wounds which will eventually ... a lifetime. "Phantom pain is very difficult to treat", ... "Mostly they prove to be highly therapy-resistant", the Professor ...
... , THURSDAY, Aug. 5 (HealthDay News) -- While maintaining ... of heart disease and diabetes, being overweight may actually ... researchers say. This new finding suggests that overweight ... open-angle glaucoma (POAG), one of the most common age-related ...
Cached Medicine News:Health News:New 'dentist' test to detect oral cancer will save lives 2Health News:New 'dentist' test to detect oral cancer will save lives 3Health News:Inhibiting prostate cancer without disturbing regular body processes 2Health News:College of Nursing awarded grant for nursing leadership in rural and underserved areas 2Health News:College of Nursing awarded grant for nursing leadership in rural and underserved areas 3Health News:UCLA researchers discover protein that shuttles RNA into cell mitochondria 2Health News:UCLA researchers discover protein that shuttles RNA into cell mitochondria 3Health News:Prosthesis with information at its fingertips 2Health News:Excess Weight May Protect Women From Type of Glaucoma 2Health News:Excess Weight May Protect Women From Type of Glaucoma 3
(Date:7/30/2015)... July 30, 2015 Future Market ... titled, "Continuous Glucose Monitoring Systems Market: Global Industry Analysis ... report, the global continuous glucose monitoring systems market was ... expected to reach US$ 788.4 Mn by 2020, registering ... to 2020. Global continuous glucose monitoring systems ...
(Date:7/30/2015)... 2015 Vermillion, Inc. (VRML), a ... announced today it will report its second ... close on Thursday, August 13, 2015, followed ... at 4:30pm Eastern.Conference Call and Webcast:  ... Pacific  Domestic: , 888-430-8691International: ...
(Date:7/30/2015)... , July 30, 2015  NanoSmart Pharmaceuticals, Inc., ... platforms, has received Orphan Drug Designation from the ... drug product that uses NanoSmart,s proprietary drug delivery ... dactinomycin for the treatment of Ewing,s sarcoma, a ... granted NanoSmart,s Orphan Drug Designation on the basis ...
Breaking Medicine Technology:Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2
... 11 Phosphagenics,Limited ("Phosphagenics") (ASX: POH; AIM: PSG; ... their joint phase 2 human clinical,trial to establish ... of metabolic syndrome is advancing at three sites ... of study participants, the,double-blind phase 2 trial, which ...
... Feb. 11 ,Pharmion (Nasdaq: PHRM ) and ... Medicines Agency (EMEA) and the European Commission (EC),designated ... Orphan,Medicinal Product for the treatment of acute myelogenous ... require that the product be,intended for the treatment ...
Cached Medicine Technology:Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 2Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 3Update on Progression of Phosphagenics and Nestle Nutrition's Phospha E(R) Trial 4Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 2Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 3Pharmion and MethylGene Announce Orphan Drug Designation Granted by the European Medicines Agency (EMEA) for MGCD0103 for the Treatment of Acute Myelogenous Leukemia 4
Quantitative determination of Fibrinogen by STA Analyzers (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
The ALB method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of albumin in serum...
The PHOS method used on the Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of phosphorus in serum....
Medicine Products: